Table 1 Description of programme years included in effect estimates and cost analyses
Programme | Year | Number of districts | Approximate annual incidence | Pyrethroid resistance status of primary vector by WHO bioassay | LLIN coverage (%) | LLIN use (%) | Insecticide product | Target dose | Expected m2 per structure | Structures sprayed | Expected persons per structure | Persons protecteda |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ghana AIRS/VectorLink Northeast and Northern Regions | 2017b | 7 | High (~ 200 per 1000 person-years) | Highly resistant (0–80% mortality in An. gambiae) | > 80 | 50–60 | Actellic® 300CS | 1 g/m2 | 54.4 | 304,648 | 2.7 | 840,438 |
2018 | 7 | 277,530 | 777,475 | |||||||||
Ghana AGAMal Upper West, Upper East Regions | 2017 | 13 | High (~ 300 per 1000 person-years) | Highly resistant (10–85% mortality in An. gambiae) | > 90 | 54–63 | Actellic® 300CS | 1 g/m2 | 40.0 | 915,140 | 1.1 | 1,028,523 |
2018 | 10 | 525,377 | 1.1 | 646,534 | ||||||||
Mali AIRS/VectorLink Mopti Region | 2017b | 4 | High (~ 300 per 1000 person-years) | Highly resistant (6–90% mortality in An. gambiae) | 85–90 | 67–78 | Actellic® 300CS | 1 g/m2 | 90.0 | 227,646 | 3.6 | 823,201 |
Mozambique AIRS/VectorLink Zambezia Province | 2017 | 7 | High (~ 400 per 1000 person-years) | Variable resistance (7–86% mortality in An. funestus) | > 90 | 85–90 | Actellic® 300CS | 1 g/m2 | 132.0 | 381,533 | 3.9 | 1,933,484 |
2018 | 4 | 120.0 | 237,194 | 4.4 | 1,121,543 | |||||||
Uganda Abt bilateral Northern and Eastern Regions | 2017b | 14 | High (~ 200 per 1000 person-years) | Highly resistant (0–80% mortality in An. gambiae) | 90 | 74 | Actellic® 300CS | 1 g/m2 | 101.0 | 1,225,644 | 3.5 | 4,227,236 |
2018 | 15 | 1,292,309 | 4,436,156 | |||||||||
Zambia AIRS/VectorLink Eastern, Luapula, Muchinga, Northern Provinces | 2017b | 4 | High (~ 200 per 1000 person-years) | Resistant (40–100% mortality in An. gambiae) | 55–80 | 40–60 | Actellic® 300CS | 1 g/m2 | 66.5 | 634,371 | 4.7 | 3,005,676 |